Bempikibart (ADX-914) is under development for the treatment of atopic dermatitis and alopecia areata. It is administered through subcutaneous route and acts by targeting interleukin-7 receptor (IL-7R ...

VI-0810 is under development for the treatment of diabetes. Vivus, a subsidiary of Icahn Enterprises LP, is developing drugs for the treatment of exocrine pancreatic insufficiency, obesity and ...

This low-calorie, low-carb commercial diet plan offers fast weight loss overseen by a health care professional.

President-elect Donald Trump‘s transition team is planning to eliminate a $7,500 electric vehicle tax credit that helps ...

The city is the epicenter of an anti-progressive movement—financed by the ultrawealthy—that aims to blur political lines and ...

And all the associated costs are huge. The Risk Adjusted Net Present Value Method considers the “success rate” for drugs going through the development process, and uses that success rate to ...

Don't miss out on the headlines from Police & Courts. Followed categories will be added to My News. New police and youth justice data released by the state government shows there were 400 serious ...

Russia and other hostile states have become increasingly brazen in adopting “gray zone” attacks against Europe and the United States, leaving defense officials with a dilemma: How to respond ...

That is below the 30% rate reported at an interim stage of the study at the International Liver Congress earlier this year, but still sufficient for GSK to take the drug forward into a phase 3 ...